Podcasts > Archived Podcasts > Industry Focus
This show is no longer producing new episodes. Check out our other shows.
Industry Focus
Healthcare: Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 10, 2016 (17:51)
Bristol-Myers Squibb's Opdivo came up short in a key lung cancer trial, causing shares to plummet. Should investors panic?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.